The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer

British Journal of Cancer

Volumn 100, Issue 5, 2009, Pages 693-700

  De Winton, E ^a   Heriot, A G ^b   Ng, M ^b   Hicks, R J ^b,c   Hogg, A ^b   Milner, A ^b   Leong, T ^b,c   Fay, M ^b   MacKay, J ^b   Drummond, E ^b   Ngan, S Y ^b,c  

^a ROYAL UNITED HOSPITAL   (United Kingdom)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Anal cancer; PET CT; Radiotherapy; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ANUS CANCER; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE FREE SURVIVAL; ENDOSCOPIC ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INGUINAL LYMPH NODE; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; THORAX RADIOGRAPHY; TREATMENT PLANNING; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 61749101973     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604897     Document Type: Article

References (36)

1. American Joint Commission on Cancer staging system (2002) AJCC Cancer Staging Handbook. Springer-Verlag: New York
2. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset J, Gonzalez D, Peiffert D, van Glabbeke M, Pierart M (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15: 2040-2049
3. Benard F, Smith R, Hustinx P, Karp K, Alavi A (1999) Clinical evaluation of processing techniques for attenuation correction with 137-Cs in wholebody PET imaging. J Nucl Med 40: 1257-1263
4. Blum R, Seymour J, Wirth A, MacManus M, Hicks R (2003) Frequent impact of (18F) fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma. Clin Lymphoma 4: 43-49
5. Cohn D, Dehdashti F, Gibb R, Mutch D, Rader J, Siegel B, Herzog T (2002) Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Gynecol Oncol 85: 179-184
6. Cotter S, Grigsby P, Siegel B, Dehdashti F, Malyapa R, Fleshman J, Birnbaum E, Wang X, Abbey E, Tan B (2006) FDG-PET/CT in the evaluation of anal carcinoma. Int J Radiat Oncol Biol Phys 65: 720-725
7. Damin D, Rosito M, Schwartsmann G (2006) Sentinel lymph node in carcinoma of the anal canal: a review. Eur J Surg Oncol 32: 247-252
8. Di Fabio F, Pinto C, Fanti C, Ceccarelli C, Gentile A, Rojas Llimpe F, Nanni C, Mutri V, Cacciari N, Martoni A (2005) Correlation between FDG-PET and pathologic response in patients with rectal cancer treated with neoadjuvant chemo-radiotherapy: first results of the Bologna Project. J Clin Oncol 23: 3623
9. Duong C, Hicks R, Weih L, Drummond E, Leong T, Michael M, Thomas R (2006) FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer. Eur J Nucl Med Mol Imaging 33: 770-778
10. Dwamena B, Sonnad S, Angobaldo J, Wahl R (1999) Metastases from nonsmall cell lung cancer: mediastinal staging in the 1990's-meta-analytic comparison of PET and CT. Radiology 213: 530-536
11. Flam M, John M, Pajak T, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L, Murray K (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14: 2527-2539
12. Frost D, Richards P, Montague E, Giacco G, Martin R (1984) Epidermoid cancer of the anorectum. Cancer 53: 1285-1293
13. Fulham M, Meikle S, Hooper P, Silver K (1997) Lesion detection in whole body FDG PET using simultaneous emission transmission acquisition and OSEM reconstruction (SET-OSEM) versus emission only (OE) and FBP reconstruction: an ROC study [abstract]. J Nucl Med 37(Suppl): 78P
14. Gould M, Maclean C, Kuschner W, Rydzak C, Owens D (2001) Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 285: 914-924
15. Hatfield P, Cooper R, Sebag-Montefiore D (2008) Involved-field, low-dose chemoradiotherapy for early-stage anal carcinoma. Int J Radiat Oncol Biol Phys 70: 419-424
16. Haustermans K, Vrieze O, DeWever W, Lerut T, Van Cutsem E, Hiele M, Ectors N, Flamen P (2002) The role of FDG-PET in the design of the radiation fields for patients with advanced esophageal cancer. Int J Radiat Oncol Biol Phys 54(Suppl): 249
17. Hellwig D, Ukena D, Paulsen F, Bamberg M, Kirsch C (2001) Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumours. Basis for discussion of the German Consensus Conference on PET in Oncology 2000. Pneumologie 55: 367-377
18. Heriot A, Hicks R, Drummond E, Keck J, Mackay J, Chen F, Kalff V (2004) Does positron emission tomography change management in primary rectal cancer? A prospective assessment. Dis Colon Rectum 47: 451-458
19. Hu K, Minsky B, Cohen A, Kelsen D, Guillem J, Paty P, Quan S (1999) 30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy. J Surg Onc 70: 71-77
20. Kalff V, Hicks R, Ware R, Greer B, Binns D, Hogg A (2002) Evaluation of high-risk melanoma: comparison of (18F) FDG and high dose 67 Ga SPET. Eur J Nucl Med Mol Imaging 29: 506-515
21. Klas J, Rothenberger D, Wong W, Madoff R (1999) Malignant tumours of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 85: 1686-1693
22. Leong T, Everitt C, Yuen K, Condron S, Hui A, Ngan S, Pitman A, Lau E, MacManus M, Binns D (2006) A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother Oncol 78: 254-261
23. MacManus M, Hicks R (2003) PET scanning in lung cancer: current status and future directions. Semin Surg Oncol 21: 149-155
24. MacManus M, Hicks R, Ball D, Klaff V, Matthews J, Salminen E, Khaw P, Wirth A, Rischin D, McKenzie A (2001) F-18 fluorodeoxyglucose positron emission tomography staging radical radiotherapy candidates with non-small cell lung carcinoma: powerful correlation with survival and high impact on treatment. Cancer 92: 886-895
25. Matsukuma K, Tsukamoto N, Matsuyama T, Ono M, Nakano H (1989) Preoperative CT study of lymph nodes in cervical cancer: its correlation with histological findings. Gynecol Oncol 33: 168-171
26. Nigro N, Vaitkevicius V, Considine S (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17: 354-356
27. Ortholan C, Ramaioli A, Peiffert D, Lusinchi A, Romestaing P, Chauveinc L, Touboul E, Peignaux K, Bruna A, de La Roche G (2005) Anal canal carcinoma: early-stage tumours < or = 10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy. Int J Radiat Oncol Biol Phys 62: 479-485
28. Reinhardt M, Ehritt-Braun C, Vogelgesang D, Ihling C, Högerle S, Mix M, Moser E, Krause T (2001) Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 218: 776-782
29. Rinne D, Baum R, Hor G, Kaufmann R (1998) Primary staging and follow-up of high-risk melanoma patients by whole-body F-18-FDG positron-emission- tomography (PET): results of a prospective study in 100 patients. Cancer 82: 1664-1671
30. Rose P, Adler L, Rodriguez M, Faulhaber P, Abdul-Karim F, Miraldi F (1999) Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol 17: 41-45
31. Ryan D, Compton C, Mayer R (2000) Carcinoma of the anal canal. N Engl J Med 342: 792-800
32. Sato H, Koh P, Bartolo D (2005) Management of anal canal cancer. Dis Colon Rectum 48: 1301-1315
33. Spaepen K, Stroobants S, Dupont P, Thomas J, Vandenberghe P, Balzarini J, De Wolf-Peeters C, Mortelmans L, Verhoef G (2001) Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity? Br J Haematol 115(2): 272-278
34. Trautmann T, Zuger J (2005) Positron emission tomography for pretreatment staging and post-treatment evaluation in cancer of the anal canal. Mol Imaging Biol 7: 309-313
35. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 348: 1049-1054
36. Weinerman P, Arger P, Coleman B, Pollack H, Banner M, Wein A (1983) Pelvic adenopathy from bladder and prostate carcinoma: detection by rapid-sequence computed tomography. Am J Roentgenol 140: 95-99